CD276 and cancer: Subsequently, univariate Cox regression analysis was performed, and the OS rates obtained revealed that CD276 served as a risk element in patients with BLCA, HNSC, ACC, COAD, LAML, LGG, MESO and UVM, whereas it was found not to be a protective factor for the various types of cancer (Fig. 9A).